Skip to content

SCHEDULE 13D/AAccepted Oct 9, 5:00 PM ET

Spyre Therapeutics, Inc. SCHEDULE 13D/A

SYRESpyre Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:00 PM

Oct 9, 2026

Filed

Oct 9, 2026

Documents

1

Size

19.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.